Voyageur Pharmaceuticals with a "big market to go for"

(via NewsDirect)

Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be used in medical imaging. Savin gives a brief summary of the note, titled "Voyageur Pharmaceuticals: Earthly profits from contrasting media."

Contact Details

Proactive Investors

[phone]

[e-mail]

Copyright (c) 2023 TheNewswire - All rights reserved.

Copyright (c) 2023 TheNewswire - All rights reserved., source Press Releases